FDA Clearance Tracker · K163049
GOLNIT Non-Absorbable PTFE Surgical Suture
Last checked: Nov 20, 2026Latest source record: Jun 21, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jun 21, 2017
Substantially Equivalent
Time to decision
232 days
Received Nov 1, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K163049
- Device name
- GOLNIT Non-Absorbable PTFE Surgical Suture
- Applicant
- Antarma Dba Golnit Sutures
- Applicant location
- Brooklyn, NY
- Received
- Nov 1, 2016
- Decided
- Jun 21, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 878.5035
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NBY. The earliest in FDA's data is K003028, decided Nov 24, 2000.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K163049
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Antarma Dba Golnit Sutures
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.